Pharmacology Flashcards
what are the two systems in the brain broadly and what neurochemical is involved in them
approach (appetitive) system = dopamine
aversive (defensive) system = seratonin
what is involved in the approach system
ventral striatum
dorsal striatum (movement)
amygdala (conditioning/ learning)
anterior cingulate (attention/ conflict/response selection)
orbitofrontal cortex (relative reward preference/ rule learning)
what is involved in the aversive system
NA / CRF / peptide transmitters
central nucleus of amygdala
hippocampus
ventroanterior and medial hypothalamus
periaqueductal gray matter
how do MAO inhibitors work
prevent the breakdown of dopamine, norepinephrine and serotonin
how do TCAs work
block the re-uptake of serotonin and norepinephrine
how do SSRIs work
block the re-uptake of serotonin
what are SSRIs and examples of them
Selective Serotonin Re-uptake Inhibitors
e.g. fluoxetine, paroxetine, citalopram, escitalopram, sertraline, fluvoxamine
how long does it take for SSRIs to work
2-3 weeks
MOA of SSRIs
1 - at baseline, 5-HT re-uptake is unaffected and the firing rate is normal
2 - with AD re-uptake of 5-HT is inhibited
3 - increased extracellular conc of 5-HT stimulated the 5-HT1a auto receptors to inhibit firing
4 - Chronic occupancy of the 5-HT1A receptor causes it to desensitize. This leads to a return of normal firing.
5 - facilitates serotonergic transmission in the presence of reuptake blockade.
S.E. of SSRIs
GI dysfunction (nausea, dyspepsia, constipation, diarrhoea, abdo pain) Short-term anxiety, agitation Insomnia Headache Dizziness Sexual dysfunction
In young patients, there is an increased risk of self harm in first few weeks
when should the use of SSRIs be avoided
in patients using NSAIDs, aspirin or warfarin
why do patients using TCAs at a high dose need an ECG
side effects include arrhythmias, heart block, tachycardia, syncope
what are the common side effects of TCAs
Constipation
Dry mouth
Blurred vision
Postural hypotension
what is the MOA of MAOIs
inhibit monoamine oxidase A and B
Increased storage and availability for release of 5-HT and NA
examples of MAOIs
phenelzine, isocarboxazid, tranylcypromine